AKTX
Akari Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.38 / 10
Netural
Fund flow score is 6.77/10, classified good, with solid inflow ratios across size segments despite overall negative trends. Analyst consensus is a single Strong Buy, but with zero historical win rate and -7% average return, making the bullish view tentative.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-05
InstitutionLadenburg Thalmann
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of AKTX?
- AKTX holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.38/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
